GS
GILD icon

GTS Securities’s Gilead Sciences GILD Stock Holding History

GTS Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-73,600
Closed -$6.17M – 2364
2024
Q3 		$6.17M Buy
73,600
+2,400
+3% +$183K 0.01% 756
2024
Q2 		$4.89M Buy
71,200
+35,000
+97% +$2.34M 0.01% 875
2024
Q1 		$2.65M Sell
36,200
-37,400
-51% -$2.88M ﹤0.01% 1287
2023
Q4 		$5.96M Sell
73,600
-39,600
-35% -$3.08M 0.01% 888
2023
Q3 		$8.48M Buy
+113,200
New +$8.71M 0.02% 670

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

GTS Securities's GILD Position: Q1 2026 in Review

GTS Securities reduced its Gilead Sciences (GILD) stake by 50% in Q1 2026, selling an estimated $995K and leaving 7,077 shares worth $986K. The position accounts for 0.03% of the portfolio, ranked #405.

GTS Securities first reported a position in GILD in Q2 2023 and has held it in 12 quarters since. The position peaked at $8.51M in Q3 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • GTS Securities held 7,077 shares of Gilead Sciences worth $986K as of Q1 2026.
  • GTS Securities sold 7,104 Gilead Sciences shares in Q1 2026, an estimated $995K.
  • Gilead Sciences made up 0.03% of GTS Securities's portfolio in Q1 2026, its #405 holding.
  • GTS Securities first reported a position in Gilead Sciences in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Gilead Sciences position peaked at $8.51M in Q3 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.